Page 5 - Cramer Charitable News Today

CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.

CNBC’s Jim Cramer sees opportunity in cybersecurity stocks including Palo Alto Networks, which his Charitable Trust owns.

CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.

Shares of Palo Alto Networks (PANW) have lately been "just kind of unstoppable," CNBC's Jim Cramer said Monday. "Those who are looking for bull markets — of…

CNBC’s Jim Cramer sees opportunity in cybersecurity stocks including Palo Alto Networks, which his Charitable Trust owns.

CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals (NASDAQ: VRTX), a biotechnology company currently in the late stages of developing a non-opioid drug to treat acute pain. 

CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals (NASDAQ: VRTX), a biotechnology company currently in the late stages of developing a non-opioid drug to treat acute pain. The company's potential candidate, known as VX-548, is being positioned to address the critical issue of opioid addiction. Vertex Pharmaceuticals primarily generates its revenue from Trikafta, a cystic fibrosis treatment. However, their strategic shift towards addressing the pain managem...

Latest Reactions on Apple from Investors and Analysts Market Movers rounded up the latest reactions on Apple from investors and analysts. The pros,

However, CNBC's Jim Cramer acknowledged Thursday that "there is some movement between Ford and the UAW."

Chipotle edged higher during Wednesday trading after Oppenheimer shared a positive outlook for the chain.